PharmaEssentia Statistics

Total Valuation

PharmaEssentia has a market cap or net worth of EUR 4.42 billion. The enterprise value is 3.88 billion.

Market Cap	4.42B
Enterprise Value	3.88B

Important Dates

The next estimated earnings date is Monday, May 12, 2025.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+3.59%
Shares Change (QoQ)	+2.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	256.15M

Valuation Ratios

The trailing PE ratio is 50.63.

PE Ratio	50.63
Forward PE	n/a
PS Ratio	15.42
PB Ratio	5.47
P/TBV Ratio	5.52
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 69.11, with an EV/FCF ratio of 78.16.

EV / Earnings	44.41
EV / Sales	14.72
EV / EBITDA	69.11
EV / EBIT	82.53
EV / FCF	78.16

Financial Position

The company has a current ratio of 9.94, with a Debt / Equity ratio of 0.04.

Current Ratio	9.94
Quick Ratio	9.34
Debt / Equity	0.04
Debt / EBITDA	0.47
Debt / FCF	0.57
Interest Coverage	78.23

Financial Efficiency

Return on equity (ROE) is 11.54% and return on invested capital (ROIC) is 4.05%.

Return on Equity (ROE)	11.54%
Return on Assets (ROA)	3.72%
Return on Invested Capital (ROIC)	4.05%
Return on Capital Employed (ROCE)	6.09%
Revenue Per Employee	2.19M
Profits Per Employee	667,038
Employee Count	131
Asset Turnover	0.33
Inventory Turnover	0.86

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +52.99% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+52.99%
50-Day Moving Average	18.03
200-Day Moving Average	19.11
Relative Strength Index (RSI)	42.25
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PharmaEssentia had revenue of EUR 286.85 million and earned 87.38 million in profits. Earnings per share was 0.26.

Revenue	286.85M
Gross Profit	252.16M
Operating Income	51.16M
Pretax Income	88.24M
Net Income	87.38M
EBITDA	54.41M
EBIT	51.16M
Earnings Per Share (EPS)	0.26

Full Income Statement

Balance Sheet

The company has 620.29 million in cash and 28.45 million in debt, giving a net cash position of 591.85 million.

Cash & Cash Equivalents	620.29M
Total Debt	28.45M
Net Cash	591.85M
Net Cash Per Share	n/a
Equity (Book Value)	809.40M
Book Value Per Share	2.43
Working Capital	673.60M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 75.05 million and capital expenditures -25.40 million, giving a free cash flow of 49.65 million.

Operating Cash Flow	75.05M
Capital Expenditures	-25.40M
Free Cash Flow	49.65M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 87.91%, with operating and profit margins of 17.83% and 30.46%.

Gross Margin	87.91%
Operating Margin	17.83%
Pretax Margin	30.76%
Profit Margin	30.46%
EBITDA Margin	18.97%
EBIT Margin	17.83%
FCF Margin	17.31%

Dividends & Yields

PharmaEssentia does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.59%
Shareholder Yield	-3.59%
Earnings Yield	1.98%
FCF Yield	1.12%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PharmaEssentia has an Altman Z-Score of 29.21.

Altman Z-Score	29.21
Piotroski F-Score	n/a